Kenneth Frazier Quotes
The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.
Frazier, Kenneth. "Letter from the Chairman and CEO." Merck 2016 Corporate Responsibility Report, Merck & Co., Inc., 2017, p. 3.
Science has the interesting characteristic that most failures are successes in the sense that scientific knowledge is gained from the failure even if it only a guide to what not to do in the future. Politics would be well served to adopt this pragmatic approach, but ideology usually prevails in politics and errors tend to be repeated if there are supported by political philosophy or ideology.
Stem cells are cells of the body that transform into all other cells as needed. Embryonic stem cells are the ones most easily transformed to create other needed cells. There was and is a large supply of embryonic stem cells but religious abortion opponents were concerned that if there were enough success there would be a market for fetal stem cells which would encourage some women to have abortions so that they could sell the embryonic stem cells. President Bush, to placate his religious right wing, had banned federal funds being used for fetal stem cell research. President Obama, who had campaigned on this issue and been elected, then overturned the ban with this quote.
Although a conservative Republican, he and most other CEOs of modern companies do not denigrate and ignore science the way many other conservatives have done over the years.
Scientific breakthroughs depend on genius, circumstances, the work of others and serendipity. None of these are very predictable which is why it is do difficult to manage a scientific enterprise and be accountable for any results. See {624867}.
Kenneth Carleton Frazier is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company (part of the Fortune 500 companies). He was elected to the American Philosophical Society in 2018.